H
Halozyme Therapeutics
Biotech & Life Sciences · San Diego, United States · Founded 1998 · IPO 2004 Unicorn
Investors
1 investor on Halozyme Therapeutics's cap table
Sourced from Dealroom's funding history. Investor profile links are shown where available.
Global footprint
Where Halozyme Therapeutics has talent and traffic
across markets
Capital deployed
Halozyme Therapeutics's 3 investments and acquisitions.
Every disclosed deal where Halozyme Therapeutics appeared as a backer or acquirer, 2022–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
3 deals across Halozyme Therapeutics's capital deployment.
Where the deals concentrate by sector, stage, and decade.
02 · Portfolio market map
Halozyme Therapeutics's portfolio, mapped.
Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.
Market sentiment
What the market is saying about Halozyme Therapeutics
An AI-synthesized read of the highest-engagement posts about Halozyme Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Halozyme Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.